COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
Related Experiment Video
Updated: Sep 28, 2025

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
Qian Yang1, Qi Jiang1, Man Man Niu1
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
No abstract available in PubMed .
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Tumor Immunotherapy
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...